FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds of formula (I)
,
in which R1 stands for a phenyl group, optionally substituted with one or several halogen atoms; R2 stands for hydrogen or a halogen atom or a cyanogroup; group -C(=O)Y, in which Y stands for a hydrogen atom or the group -NH2 or -OR3; group -C(=S)NH2; group -C(=NH)NH-OH; group -CH2OH or -CH2F; group -CH=N-OH; group -CH=CH2 or -C≡C-Ra; group (II) or (III); and Ra stands for the hydrogen atom or the (C1-C4)alkyl group; R3 stands for thehydrogen atom or the (C1-C4)alkyl group; and R4 stands for -NH2, (C1-C4)alkyl, (C1-C4)fluoroalkyl or (C3-C7)cycloalkyl group. The invention also relates to methods of obtaining compounds of formula (I), a medical preparation, a pharmaceutical composition, intermediate compounds for obtaining the formula (I) compound and the application of the formula (I) compound and intermediate compounds.
EFFECT: claimed compounds have anti-cancer activity.
21 cl, 1 tbl, 28 ex
Title | Year | Author | Number |
---|---|---|---|
PYRROLIDINYL UREA AND PYRROLIDINYL THIOUREA COMPOUNDS AS TRKA KINASE INHIBITORS | 2012 |
|
RU2606131C2 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS | 2011 |
|
RU2652638C2 |
BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
KINASE INHIBITORS | 2013 |
|
RU2637944C2 |
PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS FOR APPLICATION | 2012 |
|
RU2638552C2 |
N-PYRROLIDINYL-UREA, N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS | 2013 |
|
RU2677667C2 |
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
AMIDE DERIVATIVES OF PYROSOL | 2015 |
|
RU2658827C2 |
PYRIDAZINE DERIVATIVES AS RORc MODULATORS | 2017 |
|
RU2757571C2 |
Authors
Dates
2014-10-10—Published
2010-04-22—Filed